These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27984508)

  • 1. Characterization of ADME gene variation in 21 populations by exome sequencing.
    Hovelson DH; Xue Z; Zawistowski M; Ehm MG; Harris EC; Stocker SL; Gross AS; Jang IJ; Ieiri I; Lee JE; Cardon LR; Chissoe SL; Abecasis G; Nelson MR
    Pharmacogenet Genomics; 2017 Mar; 27(3):89-100. PubMed ID: 27984508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imputation-based assessment of next generation rare exome variant arrays.
    Martin AR; Tse G; Bustamante CD; Kenny EE
    Pac Symp Biocomput; 2014; ():241-52. PubMed ID: 24297551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-Küster-Hauser syndrome.
    Chen MJ; Wei SY; Yang WS; Wu TT; Li HY; Ho HN; Yang YS; Chen PL
    Hum Reprod; 2015 Jul; 30(7):1732-42. PubMed ID: 25924657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing.
    Silgado-Guzmán DF; Angulo-Aguado M; Morel A; Niño-Orrego MJ; Ruiz-Torres DA; Contreras Bravo NC; Restrepo CM; Ortega-Recalde O; Fonseca-Mendoza DJ
    Front Pharmacol; 2022; 13():931531. PubMed ID: 35846994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global inference of disease-causing single nucleotide variants from exome sequencing data.
    Wu M; Chen T; Jiang R
    BMC Bioinformatics; 2016 Dec; 17(Suppl 17):468. PubMed ID: 28155632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
    Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
    Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome sequencing of only seven Qataris identifies potentially deleterious variants in the Qatari population.
    Rodriguez-Flores JL; Fuller J; Hackett NR; Salit J; Malek JA; Al-Dous E; Chouchane L; Zirie M; Jayoussi A; Mahmoud MA; Crystal RG; Mezey JG
    PLoS One; 2012; 7(11):e47614. PubMed ID: 23139751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. iCall: a genotype-calling algorithm for rare, low-frequency and common variants on the Illumina exome array.
    Zhou J; Tantoso E; Wong LP; Ong RT; Bei JX; Li Y; Liu J; Khor CC; Teo YY
    Bioinformatics; 2014 Jun; 30(12):1714-20. PubMed ID: 24567545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics.
    Santos M; Niemi M; Hiratsuka M; Kumondai M; Ingelman-Sundberg M; Lauschke VM; Rodríguez-Antona C
    Genet Med; 2018 Jun; 20(6):622-629. PubMed ID: 29261188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining multiallelic complex copy number and sequence variation from high coverage exome sequencing data.
    Forni D; Martin D; Abujaber R; Sharp AJ; Sironi M; Hollox EJ
    BMC Genomics; 2015 Nov; 16():891. PubMed ID: 26526070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic content of commercial genome-wide genotyping arrays.
    Lemieux Perreault LP; Zaïd N; Cameron M; Mongrain I; Dubé MP
    Pharmacogenomics; 2018 Oct; 19(15):1159-1167. PubMed ID: 30272537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replicate exome-sequencing in a multiple-generation family: improved interpretation of next-generation sequencing data.
    Cherukuri PF; Maduro V; Fuentes-Fajardo KV; Lam K; ; Adams DR; Tifft CJ; Mullikin JC; Gahl WA; Boerkoel CF
    BMC Genomics; 2015 Nov; 16():998. PubMed ID: 26602380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of pathogenic variants from the ClinVar database in healthy people using next-generation sequencing.
    Rančelis T; Arasimavičius J; Ambrozaitytė L; Kavaliauskienė I; Domarkienė I; Karčiauskaitė D; Kučinskienė ZA; Kučinskas V
    Genet Res (Camb); 2017 Aug; 99():e6. PubMed ID: 28851476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family-based exome-sequencing approach identifies rare susceptibility variants for lithium-responsive bipolar disorder.
    Cruceanu C; Ambalavanan A; Spiegelman D; Gauthier J; Lafrenière RG; Dion PA; Alda M; Turecki G; Rouleau GA
    Genome; 2013 Oct; 56(10):634-40. PubMed ID: 24237345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted next-generation sequencing identifies pathogenic variants in familial congenital heart disease.
    Blue GM; Kirk EP; Giannoulatou E; Dunwoodie SL; Ho JW; Hilton DC; White SM; Sholler GF; Harvey RP; Winlaw DS
    J Am Coll Cardiol; 2014 Dec; 64(23):2498-506. PubMed ID: 25500235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population.
    Goljan E; Abouelhoda M; ElKalioby MM; Jabaan A; Alghithi N; Meyer BF; Monies D
    PLoS One; 2022; 17(1):e0263137. PubMed ID: 35089958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome sequencing explained: a practical guide to its clinical application.
    Seaby EG; Pengelly RJ; Ennis S
    Brief Funct Genomics; 2016 Sep; 15(5):374-84. PubMed ID: 26654982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome versus transcriptome sequencing in identifying coding region variants.
    Ku CS; Wu M; Cooper DN; Naidoo N; Pawitan Y; Pang B; Iacopetta B; Soong R
    Expert Rev Mol Diagn; 2012 Apr; 12(3):241-51. PubMed ID: 22468815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome sequencing followed by genotyping suggests SYPL2 as a susceptibility gene for morbid obesity.
    Jiao H; Arner P; Gerdhem P; Strawbridge RJ; Näslund E; Thorell A; Hamsten A; Kere J; Dahlman I
    Eur J Hum Genet; 2015 Sep; 23(9):1216-22. PubMed ID: 25406998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes.
    Lotta LA; Wang M; Yu J; Martinelli I; Yu F; Passamonti SM; Consonni D; Pappalardo E; Menegatti M; Scherer SE; Lewis LL; Akbar H; Wu Y; Bainbridge MN; Muzny DM; Mannucci PM; Gibbs RA; Peyvandi F
    BMC Med Genomics; 2012 Feb; 5():7. PubMed ID: 22353194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.